[Objective assessment of the level of comorbidity in geriatric patients with bowel cancer: relationship between the surgical results and survival]

Cir Esp. 2013 Apr;91(4):231-6. doi: 10.1016/j.ciresp.2012.07.006. Epub 2012 Dec 20.
[Article in Spanish]

Abstract

Objectives: Bowel cancer is increasing in prevalence in geriatrics (older than 65 years). The influence of comorbidities on the post-surgical results of bowel cancer is not well known. Our aim was to assess the comorbidities using the Charlson index in a geriatric population subjected to bowel cancer surgery, and analyse their influence on the postoperative results and the mortality rate.

Material and methods: The study included 115 patients (over 65 years-old and with 5 years follow-up) subjected to bowel cancer surgery in the Vic General Hospital (Barcelona) between the years 2003 and 2005. Three comorbidity groups were established using the Charlson index: absent (0 points), low (1-2 points), and high (≥ 3 points). The postoperative medical and surgical complications, as well as mortality, were determined in each of the groups.

Results: The relative risk of a medical complication adjusted for age and stage was 2.7 (95% CI; 1.07-7) and 4.3 (95% CI; 1.3-14) times higher in the low and high comorbidity groups, respectively. There were no differences in post-surgical complications between the comorbidity groups. The length of hospital stay was higher in the in the high comorbidity group compared to the group with no comorbidity (17 days compared to 26 days, P=.02). The relative risk of mortality adjusted for age and stage was 1.7 (95% CI; 1.04-3) and 2.5 (95% CI; 1.3-4.6) in the low and high comorbidity groups, respectively.

Conclusion: The presence of any level of comorbidity measured by the Charlson index is an independent predictive factor of medical complications and of an increase in overall mortality in geriatric patients subjected to bowel cancer surgery.

Publication types

  • English Abstract

MeSH terms

  • Aged
  • Aged, 80 and over
  • Colonic Neoplasms / epidemiology*
  • Colonic Neoplasms / surgery*
  • Comorbidity
  • Female
  • Humans
  • Male
  • Retrospective Studies
  • Survival Rate
  • Treatment Outcome